Infarct size and magnesium: Insights into LIMIT-2 and ISIS-4 from experimental studies

Lancet

Volumn 348, Issue 9039, 1996, Pages 1424-1426

  Baxter, G F ^a   Sumeray, M S ^a   Walker, J M ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM; MAGNESIUM SULFATE;

CELL METABOLISM; CLINICAL TRIAL; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE ARRHYTHMIA; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; REPERFUSION INJURY; SHORT SURVEY;

EID: 0030599538     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07281-9     Document Type: Note

References (24)

1. 1 Morton BC, Smith FM, McKibbon TJ, Mair RC, Poznanski WJ. Magnesium therapy in acute myocardial infarction. Magnesium Bull 1981; 1: 192-94.
2. 2 Morton BC, Smith FM, Nair RC, McKibbon TG, Poznanski WJ. The clinical effects of magnesium sulphate treatment in acute myocardial infarction. Magnesium Bull 1984; 4: 133-36.
3. 3 Morton BC, Nair RC, Smith FM, McKibbon TG, Poznanski WJ. Magnesium therapy in acute myocardial infarction: a double blind study. Magnesium 1984; 3: 346-52.
4. 4 Rasmussen HS, McNair P, Norregard P, Backer V, Lindeneg O, Balslev S. Intravenous magnesium in acute myocardial infarction. Lancet 1986; 1: 234-36.
5. 5 Rasmussen HS, Gronbaek M, Cintin C, Balslev S, Norregard P, McNair P. One-year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo. Clin Cardiol 1988; 11: 377-81.
6. 6 Smith LF, Heagerty AM, Bing RF, Barnett DB. Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality. Int J Cardiol 1986; 12: 175-80.
7. 7 Abraham AS, Rosenmann D, Kramer M, et al. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Arch Intern Med 1987; 147: 753-55.
8. 8 Feldstedt M, Bouchelouche P, Svenningsen A, et al. Failing effect of magnesium substitution in acute myocardial infarction. Eur Heart J 1988; 9: 226.
9. 9 Feldstedt M, Boesgaard S, Bouchelouche P, et al. Magnesium substitution in acute ischaemic heart syndromes. Eur Heart J 1991; 12: 1215-18.
10. 10 Shechter M, Hod H, Marks N, Kaplinsky E, Behar S, Rabinowitz B. Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol 1990; 66: 271-74.
11. 11 Ceremuzynski L, Jurgiel R, Kulakowski P, Gebalska J. Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulphate. Am Heart J 1989; 118: 1333-34.
12. 12 Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ 1991; 303: 1499-503.
13. 13 Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992; 339: 1553-58.
14. 14 ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-85.
15. 15 Haigney MCP, Silver B, Tanglao E, et al. Noninvasive measurement of tissue magnesium and correlation with cardiac levels. Circulation 1995; 92: 2190-97.
16. 16 Woods KL. Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol 1991; 32: 3-10.
17. 17 Shattock MJ, Hearse DJ, Fry CH. The ionic basis of the anti-ischemic and anti-arrhythmic properties of magnesium in the heart. J Am Coll Nutr 1987; 6: 27-33.
18. 18 Chang C, Varghese PJ, Downey J, Bloom S. Magnesium deficiency and myocardial infarct size in the dog. J Am Coll Cardiol 1985; 5: 2622-26.
19. 19 Leor J, Kloner RA. An experimental model examing the role of magnesium in the therapy of acute myocardial infarction. Am J Cardiol 1995; 75: 1292-93.
20. 20 Barros LFM, Chagas ACP, da Luz PL, Pileggi F. Magnesium treatment of acute myocardial infarction: effects on necrosis in an occlusion/reperfusion dog model. Int J Cardiol 1995; 48: 3-9.
21. 21 Christiansen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation 1995; 92: 2617-21.
22. 22 Herzog WR, Schlossberg ML, MacMurdy KS, et al. Timing of magnesium therapy affects experimental infarct size. Circulation 1995; 92: 2622-26.
23. 23 Woods KL, Fletcher S,. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1994; 343: 816-19.
24. 24 Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol 1995; 75: 391-93.